Vita Life Sciences Limited (AU:VLS) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Vita Life Sciences Limited has announced that Director Andrew O’Keefe has increased his interest in the company through the acquisition of 300,000 additional ordinary shares at $2.30 each, under the employee Long Term Incentive Plan. Following this change, which occurred on September 27, 2024, O’Keefe now holds a total of 890,000 shares. This transaction aligns with the approvals from the Board and Shareholders at the 2024 Annual General Meeting.
For further insights into AU:VLS stock, check out TipRanks’ Stock Analysis page.